Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Diamant

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 9, 2011
The longitudinal association between glycaemic control and health-related quality of life following insulin therapy optimisation in type 2 diabetes patients. A prospective observational study in secondary careT R S Hajos, F Pouwer, R de Grooth, et al.
Diabetes, Obesity & Metabolism|October 18, 2014
Is insulin the most effective injectable antihyperglycaemic therapy?J B Buse, A Peters, D Russell-Jones, et al.
European Journal of Pharmacology|February 25, 2000
Endogenous corticotropin-releasing hormone inhibits conditioned-fear-induced vagal activation in the ratM J Nijsen, G Croiset, M Diamant, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2007
Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn StudyR K Schindhelm, J M Dekker, G Nijpels, et al.
Diabetologia|January 13, 2012
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled studyB Eliasson, D Möller-Goede, K Eeg-Olofsson, et al.
Scandinavian Journal of Rheumatology|January 1, 1991
Elastolytic activity of human monocytes from synovial fluid and blood of patients with arthritis. Relations to levels of interleukin 6 and soluble interleukin 2 receptorH S Jensen, N Tvede, M Diamant, et al.
Transplantation Proceedings|October 28, 2009
Uruguayan experience with cryopreserved arterial homograftsA Esperón, E Kamaid, M Diamant, et al.
Diabetes, Obesity & Metabolism|December 5, 2015
Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight menM H A Muskiet, L Tonneijck, M M Smits, et al.
Diabetologia|June 24, 2003
A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn StudyG Bos, J M Dekker, G Nijpels, et al.
Diabetes, Obesity & Metabolism|January 13, 2012
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatmentMark S Fineman, K F Mace, M Diamant, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 9, 2011
The longitudinal association between glycaemic control and health-related quality of life following insulin therapy optimisation in type 2 diabetes patients. A prospective observational study in secondary careT R S Hajos, F Pouwer, R de Grooth, et al.
Diabetes, Obesity & Metabolism|October 18, 2014
Is insulin the most effective injectable antihyperglycaemic therapy?J B Buse, A Peters, D Russell-Jones, et al.
European Journal of Pharmacology|February 25, 2000
Endogenous corticotropin-releasing hormone inhibits conditioned-fear-induced vagal activation in the ratM J Nijsen, G Croiset, M Diamant, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2007
Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn StudyR K Schindhelm, J M Dekker, G Nijpels, et al.
Diabetologia|January 13, 2012
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled studyB Eliasson, D Möller-Goede, K Eeg-Olofsson, et al.
Scandinavian Journal of Rheumatology|January 1, 1991
Elastolytic activity of human monocytes from synovial fluid and blood of patients with arthritis. Relations to levels of interleukin 6 and soluble interleukin 2 receptorH S Jensen, N Tvede, M Diamant, et al.
Transplantation Proceedings|October 28, 2009
Uruguayan experience with cryopreserved arterial homograftsA Esperón, E Kamaid, M Diamant, et al.
Diabetes, Obesity & Metabolism|December 5, 2015
Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight menM H A Muskiet, L Tonneijck, M M Smits, et al.
Diabetologia|June 24, 2003
A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn StudyG Bos, J M Dekker, G Nijpels, et al.
Diabetes, Obesity & Metabolism|January 13, 2012
Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatmentMark S Fineman, K F Mace, M Diamant, et al.
Pageof 14